Skip to main content

GUGGENHEIM CAPITAL LLC

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1283072 Chicago, IL

Position in AMLX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$354,630
+$49,695 QoQ
Shares Held
25,513
+1.1% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

GUGGENHEIM CAPITAL LLC holds $73,564,946 across 16 Drug Manufacturers - Specialty & Generic names. AMLX ranks #14 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AMLX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $354,630 25,513
2025-12-31 $304,935 25,243
2025-09-30 $338,376 24,899
2025-06-30 $229,169 35,752
2025-03-31 $133,797 37,796
2024-12-31 $135,581 35,868
2024-09-30 $49,889 15,398
2024-06-30 $29,351 15,448
2024-03-31 $46,399 16,338
2023-12-31 $220,004 14,946